Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

A 2181Session 222

What changed between versions

75 paragraphs changed+660 words added−1365 removed

Highlighted text was added in the newer version. Struck-through text was removed.

LEGISLATIVE FISCAL ESTIMATE

ASSEMBLY COMMITTEE SUBSTITUTE FOR

ASSEMBLY, Nos. 2181 and 2188

STATE OF NEW JERSEY

222nd LEGISLATURE

DATED:ADOPTED OCTOBER 3022, 2026

SUMMARY

Synopsis:

Sponsored by:

Assemblywoman SHANIQUE SPEIGHT

District 29 (Essex and Hudson)

Assemblywoman SHAMA A. HAIDER

District 37 (Bergen)

Assemblywoman TENNILLE R. MCCOY

District 14 (Mercer and Middlesex)

Assemblywoman VERLINA REYNOLDS-JACKSON

District 15 (Hunterdon and Mercer)

Assemblywoman DAWN FANTASIA

District 24 (Morris, Sussex and Warren)

Co-Sponsored by:

Assemblywomen Carter, Assemblyman Miller, Assemblywoman Swain, Assemblyman Tully, Assemblywomen Peterpaul, Donlon, and Karabinchak

SYNOPSIS

Establishes requirements to evaluate certain people who are pregnant and who have given birth for endometriosis.

Type of Impact:

Annual State expenditure and revenue increases.

Agencies Affected:

Department of Health; Department of Human Services; Division of Consumer Affairs in the Department of Law and Public Safety.

Office of Legislative Services Estimate

Fiscal Impact

Annual

State Expenditure Increase

Indeterminate

State Revenue Increase

Indeterminate

CURRENT VERSION OF TEXT

Substitute as adopted by the Assembly Appropriations Committee.

An Act concerning endometriosis evaluations and supplementing Title 26 of the Revised Statutes.

Be It Enacted by the Senate and General Assembly of the State of New Jersey:

1. a. The Commissioner of Health shall require every licensed physician or health care practitioner in the State providing perinatal care to a pregnant person or a person who has given birth, to refer the person for an endometriosis evaluation if the person has been diagnosed with preeclampsia and subsequently shows symptoms of endometriosis.

b. The Board of Medical Examiners shall require every obstetric care provider, who is the primary caregiver for a pregnant person, or a person who seeks perinatal care within six weeks of giving birth, to in accordance with nationally recognized guidelines:

(1) provide the person with information, developed by the Department of Health, on endometriosis and potential warning signs and symptoms;

·(2) Theinform Officethe person of Legislativethe Servicesbenefits (OLS)of concludesbeing that State costs will increase by an indeterminate amountevaluated for endometriosis if the Departmentperson of Health to develop and implement an endometriosis public education program for pregnant and postpartum persons who havehas been diagnosed with preeclampsia and subsequently showshows symptoms of endometriosis.; and

· Although current research shows that persons diagnosed with endometriosis have a higher risk of developing preeclampsia during pregnancy than do persons who are not diagnosed with endometriosis, there are no publicly available data on the percentage of persons with an endometriosis diagnosis who later develop preeclampsia, or vice versa. As such, the OLS cannot anticipate the number of pregnant and postpartum persons who would ultimately be evaluated subsequent to the bill.

· Expenditures incurred by the State Board of Medical Examiners in the Division of Consumer Affairs will increase by an indeterminate amount to ensure that licensed obstetric care practitioners comply with the educational and evaluation requirements established under the bill.

· NJ FamilyCare costs may potentially increase for licensed obstetric care providers to conduct the evaluation program established under the bill and to develop a treatment plan for those persons who receive a positive result for endometriosis. The OLS, however, is unable to determine the amount by which Medicaid costs will increase under the bill, since 95 percent of NJ FamilyCare patients are enrolled in a managed care plan; the NJ FamilyCare managed care organizations’ costs are proprietary information. To the extent that NJ FamilyCare expenditures increase under the bill, State revenues will increase in the form of federal Medicaid reimbursements.

· There is the potential for annual cost savings under the NJ FamilyCare program if the bill’s requirements were to cause positive health outcomes that reduce future treatment costs.

BILL DESCRIPTION

The bill directs the Department of Health to require licensed physicians or health care practitioners who provide perinatal care to a pregnant or postpartum person to refer the person for an endometriosis evaluation, if the person has been diagnosed with preeclampsia and later shows symptoms of endometriosis.

The Board of Medical Examiners will require obstetric care providers who are the primary caregiver for a pregnant person or a postpartum person who seeks perinatal care to: (1) provide the person with Department of Health-developed information on endometriosis; (2) inform the person of the benefits of being evaluated for endometriosis if the person has been diagnosed with preeclampsia and later has symptoms of endometriosis; and (3) evaluate the person for endometriosis or refer the person for an evaluation unless the person provides a written refusal.

(3) evaluate the person for endometriosis or refer the person to a qualified obstetric care provider for an endometriosis evaluation unless the person provides written refusal.

c. The departmentcommissioner willshall develop, in consultation with the Endometriosis Foundation of America and any other community-based organization as may be designated organizationsby the commissioner, endometriosis educational information concerning endometriosis for pregnant individuals and postpartum personsindividuals who have recently given birth and have been diagnosed with preeclampsia and subsequently haveshow symptoms of endometriosis. The educational information provided shall include information on endometriosis and the potential warning signs and symptoms of endometriosis.

d. Upon receipt of a referral for an endometriosis evaluation pursuant to subsection a. or b. of this section, anthe obstetric care provider willshall beperform requiredan toevaluation and discuss any evaluationthe results with the patientperson and, if the patientperson ishas diagnoseda withpositive diagnosis of endometriosis, develop a treatment plan to minimize the person’s risk from endometriosis.

Licensed2. a. Every birthing centerscenter licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.), every federally qualified health centerscenter, and every licensed health care practitionerspractitioner providing prenatal care to a pregnant person, or postpartum care willto bea requiredperson who seeks treatment within 12 weeks of giving birth, shall adopt and adhere to adopt policies requiring a pregnant or postpartumthe person to be evaluated, as necessary, for pregnancy-related hypertensive disorders related to pregnancy, providedincluding, but not limited to, postpartum preeclampsia and hypertension, if the person exhibitsshows symptoms of the condition and has not in the current or recent pregnancy previously been diagnosed with the condition, or after the onset of such symptoms. Evaluation tools willshall be based on best practices and guidance, as determined by the American College of Obstetricians and Gynecologists or another nationally-recognized body.

These same health care entities will: (1) provide a pregnant or postpartum person with evidence-based information on pregnancy-related hypertensive disorders; (2) inform the person of the benefits of being evaluated for pregnancy-related hypertensive disorders and that the person should be evaluated under certain circumstances, unless the person declines to be evaluated; and (3) review and discuss any evaluation results with the person and, if the person is diagnosed with preeclampsia, develop an evidence-based treatment plan to minimize the person’s risk.

FISCAL ANALYSIS

EXECUTIVE BRANCH

None received.

OFFICE OF LEGISLATIVE SERVICES

The OLS concludes that Department of Health expenditures will increase by an indeterminate amount to develop and implement the endometriosis public education program and the evaluation program required under the bill. The OLS notes that the FY 2023 Appropriations Act included $200,000 for a Menstrual Health Public Awareness Campaign to educate the public about menstrual disorders, including endometriosis, and maternal health. To the extent that the department utilizes the educational materials developed for the Menstrual Health Public Awareness Campaign as part of the endometriosis education program established under this bill, departmental costs will be minimized.

The State Board of Medical Examiners in the Department of Law and Public Safety’s Division of Consumer Affairs will also realize an indeterminate expenditure increase to ensure that the State’s obstetric care providers comply with the bill’s requirements to provide pregnant and postpartum persons with the Department of Health-developed educational information concerning endometriosis, and to conduct endometriosis evaluations for certain patients who have a preeclampsia diagnosis and later show symptoms of endometriosis.

Although current research indicates that persons diagnosed with endometriosis have a higher risk of developing preeclampsia during pregnancy than do persons who are not diagnosed with endometriosis, there are no publicly available data on the percentage of persons with an endometriosis diagnosis who later develop preeclampsia, or vice versa. Given this lack of information, the OLS cannot anticipate the number of pregnant and postpartum persons who would ultimately be evaluated and counseled by an obstetric care provider.

NJ FamilyCare costs may potentially increase for licensed obstetric care providers to evaluate pregnant and postpartum enrollees who have a preeclampsia diagnosis and subsequently show symptoms of endometriosis. NJ FamilyCare costs would further increase pursuant to the bill’s requirement that obstetric care providers, in the case of a pregnant or postpartum enrollee who is diagnosed with endometriosis, develop a treatment plan to minimize the enrollee’s risk from endometriosis. Since approximately 95 percent of NJ FamilyCare patients are enrolled in a managed care plan, and the reimbursement rates that the contracted NJ FamilyCare managed care organizations negotiate with contracted providers are proprietary information, the OLS is unable to determine the amount by which NJ FamilyCare costs would increase under the bill. To the extent that NJ FamilyCare program expenditures increase under the bill, State revenues will increase in the form of federal Medicaid reimbursements.

The OLS concludes that, to the extent that individuals covered under NJ FamilyCare receive additional or more intensive treatment because of the bill’s requirement that certain health care facilities and practitioners adopt policies requiring evaluations of pregnant and postpartum patients for pregnancy-related hypertensive disorders, annual NJ FamilyCare expenditures will increase by an indeterminate amount. The OLS lacks the informational basis to determine how demand for such evaluations may change as a result of the bill and by how much the associated State costs will increase. However, any increased NJ FamilyCare expenditures for such evaluations will be eligible for additional federal Medicaid matching funds, thereby increasing annual State revenues, albeit by an indeterminate amount. The OLS also notes that there is the potential for annual cost savings under the NJ FamilyCare program if the bill’s requirements were to cause positive health outcomes that reduce future treatment costs.

b. Every birthing center licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.), every federally qualified health center, and every licensed health care practitioner providing prenatal care to a pregnant person, or postpartum care to a person who seeks treatment within 12 weeks of giving birth, shall, in accordance with nationally recognized evidence-based treatment practices:

(1) provide the person with evidence-based information on hypertensive disorders related to pregnancy preeclampsia, including, but not limited to, postpartum preeclampsia and hypertension and potential warning signs and symptoms;

(2) inform the person of the benefits of being evaluated for hypertensive disorders related to pregnancy preeclampsia, including, but not limited to, postpartum preeclampsia and hypertension, if the person shows symptoms of any such disorders, and that the person should be evaluated for hypertensive disorders related to pregnancy under the circumstances set forth in this section unless the person declines to be evaluated; and

(3) upon receipt of the results of any evaluation conducted pursuant to this section, discuss the results with the person and, if the person has a positive evaluation for preeclampsia, develop an evidence-based treatment plan to minimize the person’s risk from preeclampsia.

3. The OLS concludes that the DepartmentCommissioner of Health may adopt rules and regulations, in accordance with the “Administrative Procedure Act,” P.L.1968, c.410 (C.52:14B-1 et seq.), and the State Board of Medical Examiners, and theany Stateother Boardagency ofor Nursingboard willthat utilizeregulates existinghealth resourcescare topractitioners, shall promulgate rules and regulations as are necessary to implementeffectuate the bill’spurposes requirementsof this act.

By way of context, New Jersey has 69 State-licensed hospitals and 24 federally qualified health centers that would be affected by the bill. New Jersey State Health Assessment Data show that there were 93,668 births to New Jersey residents in 2025, the most recent year for which data are available. Of this total number, approximately 29 percent, or 26,710 births in 2025, were covered by the Medicaid program. According to the Preeclampsia Foundation, hypertensive disorders of pregnancy affect between five and eight percent of all births in the United States; moreover, the foundation reports that the rate of preeclampsia in the Unites States has risen by 25 percent over the past 20 years. Federal Centers for Disease Control and Prevention data show that, among women ages 20-49 in 2022-2023, 6.2 percent had ever been diagnosed with endometriosis.

Section:

Human Services

Analyst:

Anne Cappabianca

Senior Fiscal Analyst

Approved:

Thomas Koenig

Legislative Budget and Finance Officer

This legislative fiscal estimate has been produced by the Office of Legislative Services due to the failure of the Executive Branch to respond to our request for a fiscal note.

This fiscal estimate has been prepared pursuant to P.L.1980, c.67 (C.52:13B-6 et seq.).

4. This act shall take effect 180 days following enactment.

Back to the full text